Anaemia is a commonly diagnosed complication among patients suffering with chronic
kidney disease. If left untreated, it may affect patient quality of life. There are several causes …

Chronic kidney disease (CKD) affects approximately 10% of the worldwide population;
anaemia is a frequent complication. Inadequate erythropoietin production and absolute or …

These guidelines cover the care of patients from the period following kidney transplantation
until the transplant is no longer working or the patient dies. During the early phase …

Renal anemia is a complication of chronic kidney disease. Guidelines for safe and effective
treatment in patients with renal anemia are needed. The Japanese Society for Dialysis …

Kidney transplantation is the gold-standard treatment for many patients with end-stage renal
disease. Renal transplant recipients (RTRs) remain at an increased risk of fatal and non …

Background Several erythropoiesis‐stimulating agents (ESAs) are available for treating
anaemia in people with chronic kidney disease (CKD). Their relative efficacy (preventing …

Background Post transplantation anemia (PTA) is common among kidney transplant
patients. PTA is associated with increased graft loss and in most studies with increased …

Erythropoietin (EPO) is a glycoprotein produced mainly by the adult kidney in response to
hypoxia and is the crucial regulator of red blood cell production. EPO receptors (EPORs) …

Kidney transplantation is the best treatment for kidney failure in older patients. However, little
is known regarding changes in health-related quality of life (HRQoL) from before to after …

The management of anemia of chronic kidney disease (CKD) is often challenging. In
particular, for patients with underlying inflammation, comorbid type 2 diabetes or cancer …